ADAMA Reports Results of Fourth Quarter and Full Year of 2021
Strong Q4 performance, driven by significant price increases and continued volume growth, caps another record growth year for ADAMA and brings a marked...
Stay updated with breaking news from Portfolio Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Strong Q4 performance, driven by significant price increases and continued volume growth, caps another record growth year for ADAMA and brings a marked...
/PRNewswire/ -- SIFI S.p.A. ("SIFI" or the "Company"), a leading international ophthalmic pharmaceutical company, announced today that the U.S. Food and Drug...
This follows the previously granted ODD for polihexanide in Acanthamoeba Keratitis by the FDA and EMA. An estimated 15,660 patients with fungal keratitis are diagnosed annually in the
Press release content from PR Newswire. The AP news staff was not involved in its creation.
/CNW/ -- SIFI S.p.A. ("SIFI" or the "Company"), a leading international ophthalmic pharmaceutical company, announced today that the U.S. Food and Drug...